Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,813 | 365 | 99.8% |
| Education | $11.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $901.16 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $756.40 | 47 | $0 (2024) |
| Lilly USA, LLC | $595.37 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $518.91 | 31 | $0 (2024) |
| Astellas Pharma US Inc | $369.32 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $339.88 | 28 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $311.70 | 17 | $0 (2023) |
| PFIZER INC. | $231.71 | 16 | $0 (2024) |
| Novo Nordisk Inc | $220.96 | 14 | $0 (2023) |
| Abbott Laboratories | $215.29 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $745.36 | 44 | ABBVIE INC. ($233.85) |
| 2023 | $939.53 | 56 | Lilly USA, LLC ($194.07) |
| 2022 | $888.84 | 50 | ABBVIE INC. ($150.35) |
| 2021 | $672.42 | 43 | AbbVie Inc. ($131.54) |
| 2020 | $544.65 | 33 | AstraZeneca Pharmaceuticals LP ($151.13) |
| 2019 | $730.78 | 42 | AstraZeneca Pharmaceuticals LP ($236.82) |
| 2018 | $378.36 | 26 | Astellas Pharma US Inc ($69.53) |
| 2017 | $924.23 | 73 | Merck Sharp & Dohme Corporation ($185.78) |
All Payment Transactions
367 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Diabetes Care | ||||||
| 09/25/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Automated insulin delivery system | ||||||
| 09/19/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $14.25 | General |
| 09/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: VACCINES | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Biological | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: DIABETES | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 727 | 991 | $149,064 | $57,508 |
| 2022 | 13 | 608 | 831 | $136,864 | $55,305 |
| 2021 | 10 | 513 | 715 | $110,959 | $47,299 |
| 2020 | 13 | 592 | 774 | $110,550 | $40,897 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 288 | $69,984 | $22,400 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 104 | 104 | $25,792 | $12,588 | 48.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $13,250 | $6,755 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 100 | $17,200 | $5,223 | 30.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 39 | 39 | $5,719 | $2,798 | 48.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $5,432 | $2,148 | 39.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 127 | 199 | $1,990 | $1,672 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $2,606 | $1,287 | 49.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $1,232 | $600.60 | 48.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 41 | 61 | $1,891 | $580.72 | 30.7% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 13 | 13 | $1,040 | $457.44 | 44.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 13 | 14 | $868.00 | $446.56 | 51.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,272 | $364.04 | 28.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $444.00 | $97.11 | 21.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 29 | 43 | $344.00 | $90.20 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 180 | 333 | $71,284 | $24,282 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $21,675 | $11,704 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 112 | $16,709 | $6,130 | 36.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 19 | 19 | $9,622 | $5,289 | 55.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 32 | 33 | $4,564 | $2,190 | 48.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $3,474 | $1,763 | 50.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 37 | $2,054 | $997.33 | 48.6% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 22 | 22 | $1,760 | $784.08 | 44.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 37 | 62 | $1,922 | $594.42 | 30.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 21 | 21 | $1,014 | $567.13 | 55.9% |
About Dr. Wanda Harrison, MD
Dr. Wanda Harrison, MD is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124165972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wanda Harrison, MD has received a total of $5,824 in payments from pharmaceutical and medical device companies, with $745.36 received in 2024. These payments were reported across 367 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,813).
As a Medicare-enrolled provider, Harrison has provided services to 2,440 Medicare beneficiaries, totaling 3,311 services with total Medicare billing of $201,008. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lexington, KY
- Active Since 01/31/2007
- Last Updated 12/09/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124165972
Products in Payments
- FARXIGA (Drug) $654.59
- TRELEGY ELLIPTA (Drug) $326.80
- MOUNJARO (Drug) $321.17
- VRAYLAR (Drug) $255.20
- UBRELVY (Drug) $203.48
- MYRBETRIQ (Drug) $201.15
- JARDIANCE (Drug) $194.84
- TRULICITY (Drug) $186.77
- JANUVIA (Drug) $179.50
- SYNTHROID (Drug) $170.94
- ENTRESTO (Drug) $134.49
- AIMOVIG (Biological) $132.80
- NURTEC ODT (Drug) $132.35
- Aimovig (Biological) $127.33
- FREESTYLE LIBRE (Device) $120.50
- XARELTO (Drug) $102.35
- REXULTI (Drug) $97.05
- SHINGRIX (Biological) $95.11
- Synthroid (Drug) $90.53
- TRINTELLIX (Drug) $81.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475